July 18, 2017 / 9:13 PM / a month ago

BRIEF-NDA for Aeterna Zentaris' Macrilen granted PDUFA date

July 18 (Reuters) - Aeterna Zentaris Inc

* NDA for Macrilen for the evaluation of growth hormone deficiency in adults granted December 30, 2017 PDUFA date

* Aeterna Zentaris Inc - company also announces that Mr. Kenneth Newport is no longer a member of board of directors effective as of July 12, 2017.

* Aeterna Zentaris - been accepted as a complete response to FDA's November 5, 2014 complete response letter and granted a PDUFA date of December 30, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below